Nieves PCA, Morales MV, Francés FE, Gallegos GAC, Castro QÓ, Hurtado MR

Language: Spanish
References: 18
Page: 47-51
PDF size: 247.72 Kb.

ABSTRACT

Kikuchi’s disease, also known as histiocytic necrotizing lymphadenitis, is a rare cause of more frequent lymphadenitis in the East. It is a self-limiting disease characterized by lymphadenopathy accompanied by symptoms such as fever, weight loss, asthenia, adynamia, and leukopenia. Recurrence of Kikuchi’s disease is uncommon, but it will present with extranodal symptoms. We inform the case of a 27-year-old patient with a medical history of smoking (18 pack-years), cholecystectomy, Kikuchi-Fujimoto disease in the cervical lymph node, Gilbert’s syndrome, and a mild COVID-19 infection two months prior to admission. She began with a fever of 39.2 ^oC, diaphoresis, non-productive cough, dyspnea, nasal discharge, and neck pain. She self-medicated with anti-inflammatory drugs without improvement, so she sought medical evaluation. On examination, she exhibited hypotension, tachycardia, diaphoresis, and 88% oxygen saturation, prompting hospitalization. The autoimmune profile and Epstein- Barr infection antibodies were adverse as part of the approach. Positron emission tomography-computed tomography (PET/ CT) scan revealed hypermetabolic activity in Waldeyer’s ring and cervical lymph nodes without evidence of bone marrow or splenic involvement. Subsequently, adenoidal biopsy and excision of the right cervical lymph node were performed. Pathological analysis indicated lymphocytic infiltration, abundant macrophages, histiocytosis, areas of necrosis, and karyorrhexis, suggestive of a recurrence of Kikuchi’s disease.

REFERENCES

1. Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasiawith nuclear debris and phagocytosis. Nippon Ketsueki Gakkai Zasshi.1972; 35: 379-380.

2. Gism Elseed I, Osman H, Ahmedfiqi O, Najmi F, Al-Hebshi A.Kikuchi-Fujimoto disease: a rare benign cause of lymphadenopathythat mimics malignant lymphoma. Cureus. 2022; 14 (3): e23177.

3. Perry AM, Choi SM. Kikuchi-Fujimoto disease: a review. Arch PatholLab Med. 2018; 142 (11): 1341-1346.

4. Deaver D, Horna P, Cualing H, Sokol L. Pathogenesis, diagnosis, and managementof Kikuchi-Fujimoto disease. Cancer Control. 2014; 21 (4): 313-321.

5. Racette SD, Alexiev BA, Angarone MP, Bhasin A, Lima K, JenningsLJ et al. Kikuchi-Fujimoto disease presenting in a patient with SARSCoV-2: a case report. BMC Infect Dis. 2021; 21 (1): 740.

6. Al Ghadeer HA, AlKadhem SM, AlMajed MS, AlAmer HM, AlHabeebJA, Alomran SH et al. Kikuchi-Fujimoto disease following COVID-19.Cureus. 2022; 14 (1): e21049.

7. Saito Y, Suwa Y, Kaneko Y, Tsujiwaki M, Odagawa Y. Kikuchi-Fujimotodisease following COVID-19 infection in a 7-year-old girl: a casereport and literature review. Cureus. 2022; 14 (7): e26540.

8. Cheng CY, Sheng WH, Lo YC, Chung CS, Chen YC, Chang SC.Clinical presentations, laboratory results and outcomes of patientswith Kikuchi’s disease: emphasis on the association between recurrentKikuchi’s disease and autoimmune diseases. J Microbiol ImmunolInfect. 2010; 43 (5): 366-371.

9. Song JY, Lee J, Park DW, Sohn JW, Suh SI, Kim IS et al. Clinical outcomeand predictive factors of recurrence among patients with Kikuchi’sdisease. Int J Infect Dis. 2009; 13 (3): 322-326.

10. Faheem B, Kumar V, Ashkar H, Komal F, Sultana Y. Recurrent Kikuchi-Fujimoto disease masquerading as lymphoma successfully treated byanakinra. Cureus. 2020; 12 (11): e11655.

11. Barbat B, Jhaj R, Khurram D. Fatality in Kikuchi-Fujimoto disease: arare phenomenon. World J Clin Cases. 2017; 5 (2): 35-39.

12. Dumas G, Prendki V, Haroche J, Amoura Z, Cacoub P, Galicier Let al. Kikuchi-Fujimoto disease: retrospective study of 91 casesand review of the literature. Medicine (Baltimore). 2014; 93 (24):372-382.

13. Tsujikawa T, Tsuchida T, Imamura Y, Kobayashi M, Asahi S, ShimizuK et al. Kikuchi-Fujimoto disease: PET/CT assessment of a rarecause of cervical lymphadenopathy. Clin Nucl Med. 2011; 36 (8):661-664.

14. Kim JE, Lee EK, Lee JM, Bae SH, Choi KH, Lee YH et al. Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in children. Korean J Pediatr. 2014;57 (5): 226-231.

15. Wang S, Du B, Li X, Li Y. Positron emission tomography/computedtomography hypermetabolism of Kikuchi-Fujimoto disease mimickingmalignant lymphoma: a case report and literature review. J Int MedRes. 2021; 49 (7): 3000605211032859.

16. Seong H, Jeong YH, Lee WJ, Kim JH, Kim JH, Ahn JY et al. Splenicuptake on FDG PET/CT correlates with Kikuchi-Fujimoto diseaseseverity. Sci Rep. 2021; 11 (1): 10836.

17. Jung HJ, Lee IJ, Yoon SH. Risk assessment of recurrence andautoimmune disorders in kikuchi disease. Risk Manag Healthc Policy.2020; 13: 1687-1693.

18. Salamat S, Chan J, Jolly K, Powell G, Harrison K, Ahanger S et al.Kikuchi-Fujimoto disease and prognostic implications. Head NeckPathol. 2020; 14 (1): 272-275.